Clover Health Investments (CLOV) Share-based Compensation (2020 - 2026)

Clover Health Investments' Share-based Compensation history runs 7 years deep, the most recent figure standing at $12.3 million for Q1 2026.

• Quarterly Share-based Compensation fell 53.58% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.5 million (down 20.08% YoY) and the FY2025 annual result came in at $103.7 million, down 9.34% from the prior year.
• Share-based Compensation was $12.3 million for Q1 2026 at Clover Health Investments, down from $24.9 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $42.6 million in Q3 2022 and bottomed at $12.3 million in Q1 2026.
• A 5-year average of $31.5 million and a median of $29.6 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation grew 25.38% — and 2026, when it slumped 53.58%.
• Clover Health Investments' Share-based Compensation stood at $39.1 million in 2022, then slipped by 15.24% to $33.1 million in 2023, then dropped by 10.54% to $29.6 million in 2024, then declined by 15.94% to $24.9 million in 2025, then sank by 50.76% to $12.3 million in 2026.
• Business Quant data shows CLOV's Share-based Compensation at $12.3 million in Q1 2026, $24.9 million in Q4 2025, and $26.1 million in Q3 2025.